Bufencon Injection: Therapeutic Benefits and Maximum Dose
Bufencon injection (containing ibuprofen, not betamethasone as the expanded question suggests) is indicated for fever and pain management in rheumatoid arthritis, osteoarthritis, acute gout, and soft tissue injuries, with a maximum oral dose of 3200 mg/day for adults, though the injectable formulation dosing is not specified in the available FDA labeling. 1
Therapeutic Benefits
Bufencon injection provides anti-inflammatory and analgesic effects for:
Primary Indications:
- Rheumatoid arthritis, juvenile rheumatoid arthritis, and osteoarthritis (degenerative joint disease) 1
- Fever and pain associated with common cold, back pain, dysmenorrhea, and post-operative pain 1
Secondary Indications:
- Ankylosing spondylitis, headache, toothache, myalgia, and neuralgia 1
- Acute gout and psoriatic arthritis 1
- Soft tissue injuries including sprains and contusions 1
- Non-articular rheumatism (tendinitis, tenosynovitis, synovitis) 1
Maximum Dosing Guidelines
For Oral Formulations (as reference):
- Adults with rheumatoid arthritis, osteoarthritis, or ankylosing spondylitis: 200-600 mg per dose, 3-4 times daily, with a maximum of 3200 mg per day 1
- Mild to moderate pain or common cold: 200-400 mg per dose, 3-4 times daily for adults 1
- Juvenile rheumatoid arthritis: 30-40 mg/kg body weight divided into 3-4 portions per day 1
Pediatric Dosing (Oral):
- Ages 11-14 years: 200-250 mg per dose 1
- Ages 7-10 years: 150-200 mg per dose 1
- Ages 3-6 years: 100-150 mg per dose 1
- Ages 1-2 years: 50-100 mg per dose 1
- Children weighing less than 30 kg should not exceed 500 mg per day 1
- Administer 3-4 times daily, avoiding empty stomach administration 1
Important Clinical Considerations
Administration Precautions:
- It is advisable to avoid administering on an empty stomach to minimize gastrointestinal side effects 1
- Dosage should be appropriately adjusted by age and symptom severity 1
Critical Caveat: The FDA labeling provided specifies oral dosing only. Injectable formulation-specific dosing, concentration, and administration guidelines are not detailed in the available documentation 1. Clinicians should consult the complete prescribing information for injectable Bufencon before administration, as parenteral dosing may differ significantly from oral regimens and requires specific guidance on injection site, volume, and frequency.